Smartphone therapy for psoriasis and depression
Smart Phone Delivered Cognitive Behavioral Therapy for Adults with Psoriasis and Co-Morbid Depression Symptoms
This study is testing whether a smartphone program that combines therapy for depression with support for psoriasis can help adults feel better in both areas over eight weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06216691 on ClinicalTrials.gov |
What this trial studies
This pilot study involves adults with psoriasis and depressive symptoms participating in an 8-week coach-guided cognitive behavioral therapy (CBT) program delivered via smartphone. The study aims to assess the feasibility and acceptability of this approach, as well as its preliminary efficacy in reducing depression and psoriasis symptoms. Participants will engage with treatment modules and provide feedback on their experience, with follow-up assessments conducted at the end of the program.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a confirmed diagnosis of psoriasis and current depressive symptoms.
Not a fit: Patients who have previously participated in CBT for depression or have uncontrolled chronic medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide an accessible and effective treatment option for patients suffering from both psoriasis and depression.
How similar studies have performed: While the approach of smartphone-delivered CBT is gaining traction, this specific application for psoriasis and depression is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Adults aged 18 years of age and older * Dermatologist confirmed diagnosis of psoriasis * Current depression symptoms, defined as a PHQ-9 score of 5 or greater * Current psoriasis symptoms, defined as a scaled score of "mild" on any of the Skindex-16 subscales * Participants must be proficient in English and have access to an Android or iOS smartphone Exclusion Criteria: * Previous participation in CBT for depression * Current participation in any type of psychotherapy * Those on psychotropic medications must be taking a stable dose for 2 months prior to enrollment and be willing to remain at a stable dose during the 8-week study * Current elevated suicide risk (see Section 5.3 for details) * Individuals who are incarcerated or compulsory detained * Any uncontrolled or poorly controlled chronic medical condition that may interfere with an individual's ability to participate in the clinical trial
Where this trial is running
Boston, Massachusetts
- Brigham and Women's Hospital — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Study coordinator: Liset Chacin
- Email: lchacin@bwh.harvard.edu
- Phone: 617-264-5926
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.